GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Pretax Margin %

NewAmsterdam Pharma Co NV (FRA:KH6) Pretax Margin % : -2,576.18% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. NewAmsterdam Pharma Co NV's Pre-Tax Income for the six months ended in Dec. 2023 was €-87.38 Mil. NewAmsterdam Pharma Co NV's Revenue for the six months ended in Dec. 2023 was €3.39 Mil. Therefore, NewAmsterdam Pharma Co NV's pretax margin for the quarter that ended in Dec. 2023 was -2,576.18%.

The historical rank and industry rank for NewAmsterdam Pharma Co NV's Pretax Margin % or its related term are showing as below:

FRA:KH6' s Pretax Margin % Range Over the Past 10 Years
Min: -1255.57   Med: -638.81   Max: -22.04
Current: -1255.57


FRA:KH6's Pretax Margin % is ranked worse than
75.87% of 1032 companies
in the Biotechnology industry
Industry Median: -167.31 vs FRA:KH6: -1255.57

NewAmsterdam Pharma Co NV Pretax Margin % Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Pretax Margin % Chart

NewAmsterdam Pharma Co NV Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Pretax Margin %
- - -22.04 -1,255.52

NewAmsterdam Pharma Co NV Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial - 58.30 -1,583.85 -785.44 -2,576.18

Competitive Comparison of NewAmsterdam Pharma Co NV's Pretax Margin %

For the Biotechnology subindustry, NewAmsterdam Pharma Co NV's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NewAmsterdam Pharma Co NV's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NewAmsterdam Pharma Co NV's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where NewAmsterdam Pharma Co NV's Pretax Margin % falls into.



NewAmsterdam Pharma Co NV Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

NewAmsterdam Pharma Co NV's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-162.226/12.921
=-1,255.52 %

NewAmsterdam Pharma Co NV's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-87.384/3.392
=-2,576.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NewAmsterdam Pharma Co NV  (FRA:KH6) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


NewAmsterdam Pharma Co NV Pretax Margin % Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Traded in Other Exchanges
Address
Gooimeer 2-35, Naarden, NH, NLD, 1411 DC
NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines